Clinical trial
Medtronic Evolut™ EXPAND TAVR I Feasibility Study
NCT04639258 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Medtronic Evolut™ EXPAND TAVR I Feasibility Study
- Lead sponsor
- Medtronic Cardiovascular
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 28, 2021
- Completion date
- June 7, 2022
- Enrollment
- 11 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.